Disease-modifying antirheumatic drugs: enhancing efficacy by combination

被引：2
|
作者：
Schnabel, A [1 ]
机构：
[1] Sana Rheumazentrum Baden Wurttemberg, Klin Internist Rheumatol & Klin Immunol, D-75323 Bad Wildbad, Germany
来源：
LANCET | 2004年 / 363卷 / 9410期
关键词：
D O I：
10.1016/S0140-6736(04)15660-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：670 / 671
页数：2
相关论文
共 50 条
  • [41] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [42] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [43] Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis
    Nash, Peter
    Richette, Pascal
    Gossec, Laure
    Marchesoni, Antonio
    Ritchlin, Christopher
    Kato, Koji
    McDearmon-Blondell, Erin L.
    Lesser, Elizabeth
    McCaskill, Reva
    Feng, Dai
    Anderson, Jaclyn K.
    Ruderman, Eric M.
    [J]. RHEUMATOLOGY, 2022, 61 (08) : 3257 - 3268
  • [44] The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
    Day, Alvin Lee
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (11) : 695 - 703
  • [45] Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs
    Cees J. Haagsma
    [J]. Drugs & Aging, 1998, 13 : 281 - 289
  • [46] Clinically important drug interactions with disease-modifying antirheumatic drugs
    Haagsma, CJ
    [J]. DRUGS & AGING, 1998, 13 (04) : 281 - 289
  • [47] MANAGEMENT OF ADVERSE-EFFECTS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    WIJNANDS, MJH
    VANRIEL, PLCM
    [J]. DRUG SAFETY, 1995, 13 (04) : 219 - 227
  • [48] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - POTENTIAL EFFECTS IN OLDER PATIENTS
    GARDNER, G
    FURST, DE
    [J]. DRUGS & AGING, 1995, 7 (06) : 420 - 437
  • [49] Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis
    Lin, ATH
    Clements, PJ
    Furst, DE
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2003, 29 (02) : 409 - +
  • [50] Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry
    Munoz-Martinez, C.
    Segura-Puertas, M.
    Gomez-Moreno, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (07) : 2834 - 2842
12345